Ultrasonic Electrosurgical Devices Market Size, Share & Trends Analysis Report, By Product (Generators, Consumables), By Type, By Application, By End-use, By Region- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2033

The global ultrasonic electrosurgical devices market size was exhibited at USD 3.60 billion in 2023 and is projected to hit around USD 6.12 billion by 2033, growing at a CAGR of 5.45% during the forecast period of 2024 to 2033.

Key Takeaways:

• The ultrasonic electrosurgical consumable segment accounted for the largest revenue share of 56.7% in 2023.
• The high-intensity focused ultrasonic (HIFU) ablators held the largest share of 40.0% in 2023.
• Cardiology held the largest share of 28.8% in 2023.
• The hospital segment captured the highest market share and will hold 48.5% of the market share in 2023.
• North America accounted for the largest market share of 37.0% in 2023.

Ultrasonic Electrosurgical Devices Market Report Scope

The factors influencing market growth are the rising number of surgical procedures owing to the growing prevalence of chronic diseases, the rising adoption of minimally invasive surgeries, and developments in minimally invasive surgical techniques including laparoscopy, which have resulted in the development of ultrasonic electrosurgical devices by major market players. In addition, increasing demand for patient safety during complex surgical operations has led to the growing adoption of ultrasonic electrosurgical devices and the presence of a large number of players and the growing number of strategic initiatives to enhance their product portfolios are projected to boost market growth.

Technological development has led to an increase in the number of surgeries being performed each year. Owing to the risk of infections associated with invasive surgeries, people prefer noninvasive or minimally invasive surgeries. Furthermore, an increase in the number of road accidents, an aging population, and rising healthcare expenditure in emerging economies are among the factors likely to boost the number of surgical procedures during the forecast period. These are anticipated to positively influence revenue generation from ultrasonic electrosurgical devices. According to the U.S. Census Bureau, healthcare spending worldwide is anticipated to increase to USD 18.28 trillion by 2040, growing at a CAGR of 2.6%. According to WHO, the world’s population aged 60 years and above is expected to reach 2 billion by 2050 from 900 million in 2015. The geriatric population is more susceptible to a vast number of diseases, which is likely to increase the need to treat diseases effectively, thereby boosting the market.

The rising prevalence of various types of cancer such as breast cancer, colon cancer, prostate cancer, and lung cancer is anticipated to boost the demand for ultrasonic electrosurgical devices for the treatment and surgery of various tumors in the body. Cancer is considered a universal healthcare problem as it is one of the leading causes of death. For instance, according to National Cancer Institute, about 1,806,590 new cancer cases were diagnosed in the U.S. in 2023. In addition, according to the American Cancer Society, around 1.8 million new cancers were estimated to be diagnosed in the U.S. in 2023. Furthermore, the increasing incidence of cancer across the globe is predicted to boost the demand for ultrasonic electrosurgical devices.  For instance, according to the WHO, over 3.7 million new cancer cases are diagnosed each year in Europe. Thus, the growing prevalence of cancer throughout the globe is projected to create high growth opportunities for market players during the forecast period.

Furthermore, growing health initiatives and healthcare spending by the governments of developing and developed countries for the effective treatment of chronic disorders are expected to boost market growth. The Canadian government is investing heavily in establishing medical centers such as Centre Hospitalier Universitaire Sainte-Justine in Montreal, North Island Hospitals Project, and Centre Hospitalier de l'Université de Montréal. According to an article published by Charles E. Schumer, United States Senator for New York, VA outpatient surgical center in Monroe county received USD 6.9 million in funding for phase II development that will complement the new 84,000-square-foot VA community-based outpatient ambulatory surgical clinic. This funding was included in the president’s financial year budget. Thus, such government initiatives are expected to propel the growth of the market.

Product Insights

The ultrasonic electrosurgical consumable segment accounted for the largest revenue share of 56.7% in 2023. The ultrasonic electrosurgical consumables segment is further divided into electrosurgical handpieces, electrosurgical electrodes, electrosurgical scalpels, electrosurgical forceps, and electrosurgical pencils. The segment is growing rapidly due to the fact that they are generally disposable or have low durability compared to ultrasonic electrosurgical generators. Also, consumables are reusable in various surgical procedures and have a restricted usage cycle, hence contributing to the largest market share.

The ultrasonic electrosurgical generator segment is anticipated to grow at a lucrative growth rate during the forecast period. The generators pass an electric current through the patient’s body to conduct the surgery. Generators have different power levels and quality control measures to adjust pre-surgery, which takes care of the patient’s safety during the surgery. However, factors such as heavy initial costs, the need for repair and maintenance, and lengthy installation procedures of these devices in hospitals can impede the growth of the market.

Type Insights

The high-intensity focused ultrasonic (HIFU) ablators held the largest share of 40.0% in 2023. The segment is growing owing to various factors including lowered toxicity as compared with the other techniques of ablation, minimal pain due to non-invasiveness, low cost of procedure than surgery, suitable for patients with high risk as it involves a lower rate of anesthesia, faster recovery rate than the traditional surgical procedures, low risk of infection, and bleeding can be clogged with the help of ultrasound during the procedure.

The ultrasonic surgical ablation systems are expected to be the fastest growing segment during the forecast period owing to the incidence of cardiovascular disorders, growing demand for minimally invasive cardiac surgeries for its treatment, rising prevalence of cancer and chronic pain, growing geriatric population, and technological advancements in the ultrasonic surgical ablation systems.

Application Insights

Cardiology held the largest share of 28.8% in 2023. The factors such as rising cases of cardiac disorders are expected to favor the market growth. As per the CDC, coronary heart disease is among the most common type of heart disease, and around 365,914 people died in 2017 due to this. Also, as per the WHO, about 17.9 million people die of cardiovascular disorders each year. Hence, the increasing prevalence of cardiovascular diseases globally is anticipated to boost market growth.

The gynecology segment is expected to show significant growth during the forecast period. Gynecology is a broader aspect of including all female reproductive organ disorders. These surgeries involve the use of surgical tools such as laparoscopes and hysteroscopies. The growing development of ultrasonic electrosurgical devices for gynecology by key players is expected to contribute towards segment growth.

End Use Insights

The hospital segment captured the highest market share and hold 48.5% market share in 2023. Hospital is the largest revenue-generating segment of the market, attributed to a huge number of cases and preventive surgical procedures being carried out in these settings. Around 125.7 million casualty department visits were reported in the U.S. with the surge in the number of surgeries, such as kidney & liver transplants and angioplasty. In addition, the presence of well-qualified medical experts in one place is fueling the market growth. Ambulatory Surgical Centers (ASCs) are projected to record the highest CAGR of 5.5% during the forecast period. This can be attributed to lower out-of-pocket costs, better patient accessibility, and decreased facility costs.

Regional Insights

North America accounted for the largest market share of 37.0% in 2023. This growth can mainly be attributed to the increasing number of preventive surgeries, and growing burden of chronic disorders such as cancer, diabetes, and autoimmune diseases, the increasing adoption of technologically advanced devices, and rising preference for minimally invasive surgical procedures.

The Asia Pacific is expected to show the fastest growth rate of 5.89% during the forecast period. This growth can be attributed to various factors, such as the high adoption of advanced technologies, the rising prevalence of chronic disorders, the increasing reimbursement scenario, the presence of a large geriatric population, the growing demand for minimally invasive procedures over traditional methods, and the increased need for laparoscopic surgery. In addition, key market players usually invest in developing countries to establish their footprint in the new marketplace to check the huge demand for ultrasonic electro-surgery devices.

Some of the prominent players in the ultrasonic electrosurgical device market include:

Ethicon - Endo-Surgery

Olympus Corporation

Medtronic

Misonix Inc

BOWA-electronic GmbH

Söring GmbH

Advanced Instrumentations

Reach Surgical

ITALIA MEDICA SRL.

SonaCare Medical

Miconvey

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the global ultrasonic electrosurgical devices market.

Product

• Generators
• Consumables

Type

• High-intensity Focused Ultrasonic (HIFU) Ablators
• Magnetic Resonance-guided Focused Ultrasonic (MRGFUS) Ablators
• Ultrasonic Surgical Ablation Systems
• Shock Wave Therapy Systems

Application

• Cardiology
• Gynecology
• General Surgery
• Urology
• Bariatric Surgery
• Others

End Use

• Hospitals
• Ambulatory Surgical Centers
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)